Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor.
about
Medical treatment of renal cancer: new horizonsIncreased alpha-defensin expression is associated with risk of coronary heart disease: a feasible predictive inflammatory biomarker of coronary heart disease in hyperlipidemia patientsPrognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis.Prognostic Significance of Early Tumor Shrinkage Under Second-Line Targeted Therapy for Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Study in Japan.Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate.Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis.
P2860
Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Prognostic factors in second-l ...... tor tyrosine kinase inhibitor.
@en
Prognostic factors in second-l ...... tor tyrosine kinase inhibitor.
@nl
type
label
Prognostic factors in second-l ...... tor tyrosine kinase inhibitor.
@en
Prognostic factors in second-l ...... tor tyrosine kinase inhibitor.
@nl
prefLabel
Prognostic factors in second-l ...... tor tyrosine kinase inhibitor.
@en
Prognostic factors in second-l ...... tor tyrosine kinase inhibitor.
@nl
P2093
P2860
P50
P1433
P1476
Prognostic factors in second-l ...... ptor tyrosine kinase inhibitor
@en
P2093
Anne Sacré
Clement Korenbaum
Evelyne Lerut
Herlinde Dumez
Mickael Burgy
Pascal Wolter
Patrick Schöffski
Philippe Barthélémy
Raymond Oyen
Tine Loyson
P2860
P304
P356
10.3109/0284186X.2015.1099731
P577
2015-10-23T00:00:00Z